These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35713201)
1. Ultrasensitive Fibroblast Activation Protein-α-Activated Fluorogenic Probe Enables Selective Imaging and Killing of Melanoma Liu SY; Wang H; Nie G ACS Sens; 2022 Jul; 7(7):1837-1846. PubMed ID: 35713201 [TBL] [Abstract][Full Text] [Related]
2. Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha. Li J; Chen K; Liu H; Cheng K; Yang M; Zhang J; Cheng JD; Zhang Y; Cheng Z Bioconjug Chem; 2012 Aug; 23(8):1704-11. PubMed ID: 22812530 [TBL] [Abstract][Full Text] [Related]
3. A Novel Chemiluminescence Probe for Sensitive Detection of Fibroblast Activation Protein-Alpha In Vitro and in Living Systems. Fu A; Wang H; Huo T; Li X; Fu W; Huang R; Cao Z Anal Chem; 2021 Apr; 93(16):6501-6507. PubMed ID: 33866786 [TBL] [Abstract][Full Text] [Related]
4. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. Aertgeerts K; Levin I; Shi L; Snell GP; Jennings A; Prasad GS; Zhang Y; Kraus ML; Salakian S; Sridhar V; Wijnands R; Tennant MG J Biol Chem; 2005 May; 280(20):19441-4. PubMed ID: 15809306 [TBL] [Abstract][Full Text] [Related]
5. A self-immobilizing near-infrared fluorogenic probe for in vivo imaging of fibroblast activation protein-α. Chen Y; Du J; Meng X; Wu LL; Zhang Q; Han X; Zhang L; Wang Q; Hu HY Talanta; 2024 Oct; 278():126475. PubMed ID: 38944939 [TBL] [Abstract][Full Text] [Related]
6. A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging. Ding Y; Huang Z; Luo Y; Lin H; Wang J; Zeng Z; Zhang T; Chen Y; Gong Y; Zhang M; Zhao C Acta Biomater; 2024 Oct; 187():316-327. PubMed ID: 39151666 [TBL] [Abstract][Full Text] [Related]
7. Afterglow Resonance Energy Transfer Inhibition for Fibroblast Activation Protein-α Assay. Feng F; Chen X; Li G; Liang S; Hong Z; Wang HF ACS Sens; 2018 Sep; 3(9):1846-1854. PubMed ID: 30188115 [TBL] [Abstract][Full Text] [Related]
8. The EMT-related transcription factor snail up-regulates FAPα in malignant melanoma cells. Yi Y; Wang Z; Sun Y; Chen J; Zhang B; Wu M; Li T; Hu L; Zeng J Exp Cell Res; 2018 Mar; 364(2):160-167. PubMed ID: 29410133 [TBL] [Abstract][Full Text] [Related]
9. Epitope-based minigene vaccine targeting fibroblast activation protein α induces specific immune responses and anti-tumor effects in 4 T1 murine breast cancer model. Zhang FF; Qiao Y; Xie Y; Liu C; Wu H; Wu JX; Yu XH; Kong W; Zhang HH Int Immunopharmacol; 2022 Nov; 112():109237. PubMed ID: 36152535 [TBL] [Abstract][Full Text] [Related]
10. Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α. Chai XP; Sun GL; Fang YF; Hu LH; Liu X; Zhang XW Acta Pharmacol Sin; 2018 Mar; 39(3):415-424. PubMed ID: 29119969 [TBL] [Abstract][Full Text] [Related]
11. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Ramirez-Montagut T; Blachere NE; Sviderskaya EV; Bennett DC; Rettig WJ; Garin-Chesa P; Houghton AN Oncogene; 2004 Jul; 23(32):5435-46. PubMed ID: 15133496 [TBL] [Abstract][Full Text] [Related]
12. Bioluminescence imaging of fibroblast activation protein-alpha in vivo and human plasma with highly sensitive probe. Zhang L; Ying W; Sheng Z; Lv L; Gao J; Xue Y; Liu L Anal Biochem; 2022 Oct; 655():114859. PubMed ID: 35988797 [TBL] [Abstract][Full Text] [Related]
13. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention. Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501 [TBL] [Abstract][Full Text] [Related]
14. Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells. Yang L; Ma L; Lai D Acta Biochim Biophys Sin (Shanghai); 2013 Nov; 45(11):928-37. PubMed ID: 24028972 [TBL] [Abstract][Full Text] [Related]
15. A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy. Wang J; Li Q; Li X; Yuan W; Huang S; Cai S; Xu J Eur J Pharmacol; 2017 Nov; 815():166-172. PubMed ID: 28919026 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug. Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542 [TBL] [Abstract][Full Text] [Related]
17. Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer. Xia Q; Zhang FF; Geng F; Liu CL; Wang YQ; Xu P; Lu ZZ; Xie Y; Wu H; Chen Y; Zhang Y; Kong W; Yu XH; Zhang HH Cell Immunol; 2016 Dec; 310():89-98. PubMed ID: 27545090 [TBL] [Abstract][Full Text] [Related]
18. MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα. Yu T; Gong L; Li W; Zuo Q; Cai D; Mao H; Wang L; Lin J; Xiao B Cancer Biomark; 2020; 27(4):471-484. PubMed ID: 32116236 [TBL] [Abstract][Full Text] [Related]